Global Cerebral Oximetry Monitoring Market is valued at approximately USD 189.04 million in 2021 and is anticipated to grow with a healthy growth rate of more than 7.20% over the forecast period 2022-2029. During the perioperative period of cardiovascular surgeries, cerebral oximetry based on near-infrared spectroscopy (NIRS) is employed more frequently. It is a non-invasive technique that can keep track of the frontal cortex's local oxygen saturation. The Cerebral Oximetry Monitoring Market is expanding because of factors such as the growing geriatric population and an increasing number of diseases such as cardiovascular and neurological disorders. However, the high cost of cerebral oximetry monitoring devices may halt market growth.
According to the centres for disease control and prevention, 697,000 Americans are expected to have coronary artery disease (CAD) in 2020 as a result of adopting a western lifestyle, heavy drinking, heavy smoking, and inactivity (CDC). As CAD cases increase, it is expected that the need for cerebral oximetry monitoring devices to perform safe CAD surgery would rise. Aging and obese populations are also more likely to develop chronic diseases. The World Bank Group projects that by 2050, there will be 1.5 billion older people in the world, up from the current 727 million estimate of 2020.In addition, advancements in product development and rising approval by various regulatory bodies are creating lucrative growth in the market. For instance, Masimo got FDA approval in August 2020 to use its "O3 Regional Oximetry" technology to monitor the oxygenation saturation of somatic tissues and the variations between oxyhemoglobin, hemoglobin, and deoxyhemoglobin in adult brains.
The key regions considered for the Global Cerebral Oximetry Monitoring Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of branded products and the region's increasing disease prevalence. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, an increase in the number of collaborations for product development, geographic expansion of key players, and active participation of government organizations in the market space.
Major market player included in this report are:
- Masimo
- Medtronic
- Edwards Lifesciences Corporation
- Nonin Medical Inc
- ISS, Inc.
- Hamamatsu Photonics K.K.
- Mespere LifeSciences Inc
- GE Healthcare
- Terumo Cardiovascular Systems Corporation
- Ornim Medical
Recent Developments in the Market:
- In December 2021, The FDA has granted 510(k) approval for the Medtronic PLC INVOS 7100 cerebral/somatic oximetry device for use in pediatric patients. The INVOS system enables pediatric clinicians caring for neonates, premature infants, children, and other patients to make timely decisions on ventilation, hemodynamic management, and resuscitation.
- In August 2020, The FDA approved the use of O3 Regional Oximetry to measure the oxygenation saturation of somatic tissues in all patient groups as well as the relative changes in hemoglobin, oxyhemoglobin, and deoxyhemoglobin in adult brains.
Global Cerebral Oximetry Monitoring Market Report Scope:
- Historical Data 2019-2020-2021
- Base Year for Estimation 2021
- Forecast period 2022-2029
- Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
- Segments Covered Application, Age, End Use, Region
- Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
- Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below.
By Application:
- Cardiac Surgery
- Vascular Surgery
- Others
By Age:
By End Use:
- Hospitals & Clinics
- Ambulatory Surgical Centers
- Others
By Region:
- North America
- U.S.
- Canada
- Europe
- UK
- Germany
- France
- Spain
- Italy
- ROE
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- RoAPAC
- Latin America
- Brazil
- Mexico
- RoLA
- Rest of the World
Table of Contents
Chapter 1. Executive Summary
- 1.1. Market Snapshot
- 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Million)
- 1.2.1. Cerebral Oximetry Monitoring Market, by Region, 2019-2029 (USD Million)
- 1.2.2. Cerebral Oximetry Monitoring Market, by Application, 2019-2029 (USD Million)
- 1.2.3. Cerebral Oximetry Monitoring Market, by Age Group, 2019-2029 (USD Million)
- 1.2.4. Cerebral Oximetry Monitoring Market, by End Use, 2019-2029 (USD Million)
- 1.3. Key Trends
- 1.4. Estimation Methodology
- 1.5. Research Assumption
Chapter 2. Global Cerebral Oximetry Monitoring Market Definition and Scope
- 2.1. Objective of the Study
- 2.2. Market Definition & Scope
- 2.2.1. Scope of the Study
- 2.2.2. Industry Evolution
- 2.3. Years Considered for the Study
- 2.4. Currency Conversion Rates
Chapter 3. Global Cerebral Oximetry Monitoring Market Dynamics
- 3.1. Cerebral Oximetry Monitoring Market Impact Analysis (2019-2029)
- 3.1.1. Market Drivers
- 3.1.1.1. Growing Geriatric Population
- 3.1.1.2. Increasing number of diseases such as cardiovascular and neurological disorders
- 3.1.2. Market Challenges
- 3.1.2.1. High cost of cerebral oximetry monitoring device
- 3.1.3. Market Opportunities
- 3.1.3.1. Advancements in product development
- 3.1.3.2. Rising approval by various regulatory bodies
Chapter 4. Global Cerebral Oximetry Monitoring Market Industry Analysis
- 4.1. Porter's 5 Force Model
- 4.1.1. Bargaining Power of Suppliers
- 4.1.2. Bargaining Power of Buyers
- 4.1.3. Threat of New Entrants
- 4.1.4. Threat of Substitutes
- 4.1.5. Competitive Rivalry
- 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
- 4.3. PEST Analysis
- 4.3.1. Political
- 4.3.2. Economical
- 4.3.3. Social
- 4.3.4. Technological
- 4.4. Top investment opportunity
- 4.5. Top winning strategies
- 4.6. Industry Experts Prospective
- 4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
- 5.1. Assessment of the overall impact of COVID-19 on the industry
- 5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Cerebral Oximetry Monitoring Market, by Application
- 6.1. Market Snapshot
- 6.2. Global Cerebral Oximetry Monitoring Market by Application, Performance - Potential Analysis
- 6.3. Global Cerebral Oximetry Monitoring Market Estimates & Forecasts by Application 2019-2029 (USD Million)
- 6.4. Cerebral Oximetry Monitoring Market, Sub Segment Analysis
- 6.4.1. Cardiac Surgery
- 6.4.2. Vascular Surgery
- 6.4.3. Others
Chapter 7. Global Cerebral Oximetry Monitoring Market, by Age Group
- 7.1. Market Snapshot
- 7.2. Global Cerebral Oximetry Monitoring Market by Age Group, Performance - Potential Analysis
- 7.3. Global Cerebral Oximetry Monitoring Market Estimates & Forecasts by Age Group 2019-2029 (USD Million)
- 7.4. Cerebral Oximetry Monitoring Market, Sub Segment Analysis
- 7.4.1. Pediatric
- 7.4.2. Adult
Chapter 8. Global Cerebral Oximetry Monitoring Market, by End Use
- 8.1. Market Snapshot
- 8.2. Global Cerebral Oximetry Monitoring Market by End Use, Performance - Potential Analysis
- 8.3. Global Cerebral Oximetry Monitoring Market Estimates & Forecasts by End Use 2019-2029 (USD Million)
- 8.4. Cerebral Oximetry Monitoring Market, Sub Segment Analysis
- 8.4.1. Hospitals & Clinics
- 8.4.2. Ambulatory Surgical Centers
- 8.4.3. Others
Chapter 9. Global Cerebral Oximetry Monitoring Market, Regional Analysis
- 9.1. Cerebral Oximetry Monitoring Market, Regional Market Snapshot
- 9.2. North America Cerebral Oximetry Monitoring Market
- 9.2.1. U.S. Cerebral Oximetry Monitoring Market
- 9.2.1.1. Application breakdown estimates & forecasts, 2019-2029
- 9.2.1.2. Age Group breakdown estimates & forecasts, 2019-2029
- 9.2.1.3. End Use breakdown estimates & forecasts, 2019-2029
- 9.2.2. Canada Cerebral Oximetry Monitoring Market
- 9.3. Europe Cerebral Oximetry Monitoring Market Snapshot
- 9.3.1. U.K. Cerebral Oximetry Monitoring Market
- 9.3.2. Germany Cerebral Oximetry Monitoring Market
- 9.3.3. France Cerebral Oximetry Monitoring Market
- 9.3.4. Spain Cerebral Oximetry Monitoring Market
- 9.3.5. Italy Cerebral Oximetry Monitoring Market
- 9.3.6. Rest of Europe Cerebral Oximetry Monitoring Market
- 9.4. Asia-Pacific Cerebral Oximetry Monitoring Market Snapshot
- 9.4.1. China Cerebral Oximetry Monitoring Market
- 9.4.2. India Cerebral Oximetry Monitoring Market
- 9.4.3. Japan Cerebral Oximetry Monitoring Market
- 9.4.4. Australia Cerebral Oximetry Monitoring Market
- 9.4.5. South Korea Cerebral Oximetry Monitoring Market
- 9.4.6. Rest of Asia Pacific Cerebral Oximetry Monitoring Market
- 9.5. Latin America Cerebral Oximetry Monitoring Market Snapshot
- 9.5.1. Brazil Cerebral Oximetry Monitoring Market
- 9.5.2. Mexico Cerebral Oximetry Monitoring Market
- 9.5.3. Rest of Latin America Cerebral Oximetry Monitoring Market
- 9.6. Rest of The World Cerebral Oximetry Monitoring Market
Chapter 10. Competitive Intelligence
- 10.1. Top Market Strategies
- 10.2. Company Profiles
- 10.2.1. Masimo
- 10.2.1.1. Key Information
- 10.2.1.2. Overview
- 10.2.1.3. Financial (Subject to Data Availability)
- 10.2.1.4. Product Summary
- 10.2.1.5. Recent Developments
- 10.2.2. Medtronic
- 10.2.3. Edwards Lifesciences Corporation
- 10.2.4. Nonin Medical Inc
- 10.2.5. ISS, Inc.
- 10.2.6. Hamamatsu Photonics K.K.
- 10.2.7. Mespere LifeSciences Inc
- 10.2.8. GE Healthcare
- 10.2.9. Terumo Cardiovascular Systems Corporation
- 10.2.10. Ornim Medical
Chapter 11. Research Process
- 11.1. Research Process
- 11.1.1. Data Mining
- 11.1.2. Analysis
- 11.1.3. Market Estimation
- 11.1.4. Validation
- 11.1.5. Publishing
- 11.2. Research Attributes
- 11.3. Research Assumption